tetradecanoylphorbol acetate and Adenocarcinoma, Clear Cell

tetradecanoylphorbol acetate has been researched along with Adenocarcinoma, Clear Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Elmenhorst, K; Kononen, J; Mirlacher, M; Moch, H; Schraml, P; Simon, R; Struckmann, K	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and Adenocarcinoma, Clear Cell

Article	Year
Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma. Cancer research, 2004, Mar-01, Volume: 64, Issue:5 Topics: Adenocarcinoma, Clear Cell; Blotting, Northern; Carcinoma, Renal Cell; Cell Count; Cell Cycle; Cell Line, Tumor; Gene Expression Regulation; Genes, Tumor Suppressor; Humans; Immediate-Early Proteins; In Situ Hybridization; Kidney Neoplasms; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetradecanoylphorbol Acetate; Tumor Suppressor Proteins	2004

Article

Year

Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma.

Cancer research, 2004, Mar-01, Volume: 64, Issue:5

Topics: Adenocarcinoma, Clear Cell; Blotting, Northern; Carcinoma, Renal Cell; Cell Count; Cell Cycle; Cell Line, Tumor; Gene Expression Regulation; Genes, Tumor Suppressor; Humans; Immediate-Early Proteins; In Situ Hybridization; Kidney Neoplasms; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetradecanoylphorbol Acetate; Tumor Suppressor Proteins

2004